Patient Guide: Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06662162
Status: 🟢 Enrolling Now
Condition: Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase: NA

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Albury, New South Wales
  • • Sydney, New South Wales
  • • Hobart, Tasmania
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration - Join Clinical Trial NCTNCT06662162

How to Join This Clinical Trial - NCTNCT06662162

Learn how to participate in this NA trial studying an investigational therapy for Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration
Treatment Being Tested
Investigational treatment
Study Phase
NA - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06662162 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Albury, New South Wales 2640 - Australia

Status: RECRUITING

Clinical Research Site

Sydney, New South Wales 2000 - Australia

Status: RECRUITING

Clinical Research Site

Hobart, Tasmania 7000 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, Victoria 5000 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

East Melbourne, Victoria - Australia

Status: RECRUITING

Clinical Research Site

Remuera, Auckland 1050 - New Zealand

Status: RECRUITING

Clinical Research Site

Christchurch, - New Zealand

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this NA clinical trial for Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Intermediate AMD, Geographic Atrophy Secondary to Age-related Macular Degeneration:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships